Net proceeds from the offering, which is targeting at least $8.5 million, will be used to hasten product development, to create a CLIA laboratory, and to hire a sales and marketing team in the US.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.